RESMED INC (RMD) Fundamental Analysis & Valuation
NYSE:RMD • US7611521078
Current stock price
228.19 USD
+0.22 (+0.1%)
At close:
228.19 USD
0 (0%)
After Hours:
This RMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. RMD Profitability Analysis
1.1 Basic Checks
- In the past year RMD was profitable.
- In the past year RMD had a positive cash flow from operations.
- Each year in the past 5 years RMD has been profitable.
- RMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- RMD has a better Return On Assets (17.47%) than 97.35% of its industry peers.
- RMD has a better Return On Equity (23.51%) than 95.77% of its industry peers.
- RMD's Return On Invested Capital of 20.84% is amongst the best of the industry. RMD outperforms 97.35% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for RMD is significantly above the industry average of 9.31%.
- The last Return On Invested Capital (20.84%) for RMD is above the 3 year average (18.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.47% | ||
| ROE | 23.51% | ||
| ROIC | 20.84% |
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
1.3 Margins
- Looking at the Profit Margin, with a value of 27.53%, RMD belongs to the top of the industry, outperforming 97.35% of the companies in the same industry.
- In the last couple of years the Profit Margin of RMD has grown nicely.
- RMD has a better Operating Margin (34.11%) than 99.47% of its industry peers.
- In the last couple of years the Operating Margin of RMD has grown nicely.
- Looking at the Gross Margin, with a value of 60.85%, RMD is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
- In the last couple of years the Gross Margin of RMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.11% | ||
| PM (TTM) | 27.53% | ||
| GM | 60.85% |
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
2. RMD Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RMD is creating value.
- Compared to 1 year ago, RMD has less shares outstanding
- Compared to 5 years ago, RMD has more shares outstanding
- The debt/assets ratio for RMD has been reduced compared to a year ago.
2.2 Solvency
- RMD has an Altman-Z score of 11.94. This indicates that RMD is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 11.94, RMD belongs to the top of the industry, outperforming 93.12% of the companies in the same industry.
- RMD has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.37, RMD belongs to the best of the industry, outperforming 91.53% of the companies in the same industry.
- A Debt/Equity ratio of 0.06 indicates that RMD is not too dependend on debt financing.
- RMD's Debt to Equity ratio of 0.06 is fine compared to the rest of the industry. RMD outperforms 67.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.37 | ||
| Altman-Z | 11.94 |
ROIC/WACC1.98
WACC10.55%
2.3 Liquidity
- RMD has a Current Ratio of 3.06. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.
- RMD has a Current ratio of 3.06. This is comparable to the rest of the industry: RMD outperforms 56.08% of its industry peers.
- RMD has a Quick Ratio of 2.32. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of RMD (2.32) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.06 | ||
| Quick Ratio | 2.32 |
3. RMD Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 16.29% over the past year.
- The Earnings Per Share has been growing by 14.94% on average over the past years. This is quite good.
- Looking at the last year, RMD shows a quite strong growth in Revenue. The Revenue has grown by 9.57% in the last year.
- The Revenue has been growing by 11.72% on average over the past years. This is quite good.
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%
3.2 Future
- RMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.77% yearly.
- The Revenue is expected to grow by 8.40% on average over the next years. This is quite good.
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.77%
Revenue Next Year9.97%
Revenue Next 2Y8.67%
Revenue Next 3Y7.92%
Revenue Next 5Y8.4%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. RMD Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 22.20 indicates a rather expensive valuation of RMD.
- Based on the Price/Earnings ratio, RMD is valued a bit cheaper than 76.19% of the companies in the same industry.
- When comparing the Price/Earnings ratio of RMD to the average of the S&P500 Index (25.50), we can say RMD is valued inline with the index average.
- The Price/Forward Earnings ratio is 18.58, which indicates a rather expensive current valuation of RMD.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of RMD indicates a rather cheap valuation: RMD is cheaper than 80.95% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 22.67. RMD is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.2 | ||
| Fwd PE | 18.58 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, RMD is valued a bit cheaper than 77.25% of the companies in the same industry.
- 90.48% of the companies in the same industry are more expensive than RMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.71 | ||
| EV/EBITDA | 15.86 |
4.3 Compensation for Growth
- RMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of RMD may justify a higher PE ratio.
PEG (NY)1.35
PEG (5Y)1.49
EPS Next 2Y13.39%
EPS Next 3Y11.65%
5. RMD Dividend Analysis
5.1 Amount
- RMD has a Yearly Dividend Yield of 1.06%. Purely for dividend investing, there may be better candidates out there.
- RMD's Dividend Yield is rather good when compared to the industry average which is at 0.24. RMD pays more dividend than 93.12% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, RMD's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.06% |
5.2 History
- On average, the dividend of RMD grows each year by 6.33%, which is quite nice.
- RMD has been paying a dividend for at least 10 years, so it has a reliable track record.
- RMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.33%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
- 22.25% of the earnings are spent on dividend by RMD. This is a low number and sustainable payout ratio.
- RMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.25%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
RMD Fundamentals: All Metrics, Ratios and Statistics
228.19
+0.22 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29 2026-01-29/amc
Earnings (Next)04-21 2026-04-21
Inst Owners68.21%
Inst Owner Change5.84%
Ins Owners0.49%
Ins Owner Change-0.27%
Market Cap33.24B
Revenue(TTM)5.40B
Net Income(TTM)1.49B
Analysts74.4
Price Target303.44 (32.98%)
Short Float %8.17%
Short Ratio10.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.06% |
Yearly Dividend2.12
Dividend Growth(5Y)6.33%
DP22.25%
Div Incr Years12
Div Non Decr Years12
Ex-Date02-12 2026-02-12 (0.6)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.49%
Min EPS beat(2)-1.16%
Max EPS beat(2)2.15%
EPS beat(4)2
Avg EPS beat(4)0.54%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.15%
EPS beat(8)5
Avg EPS beat(8)2.85%
EPS beat(12)8
Avg EPS beat(12)2.12%
EPS beat(16)10
Avg EPS beat(16)1.2%
Revenue beat(2)1
Avg Revenue beat(2)0.14%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)0.91%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)0.91%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)0.61%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)-0.03%
PT rev (3m)1.11%
EPS NQ rev (1m)-0.08%
EPS NQ rev (3m)1.14%
EPS NY rev (1m)0%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.2 | ||
| Fwd PE | 18.58 | ||
| P/S | 6.16 | ||
| P/FCF | 18.71 | ||
| P/OCF | 17.36 | ||
| P/B | 5.26 | ||
| P/tB | 11.68 | ||
| EV/EBITDA | 15.86 |
EPS(TTM)10.28
EY4.51%
EPS(NY)12.28
Fwd EY5.38%
FCF(TTM)12.2
FCFY5.34%
OCF(TTM)13.14
OCFY5.76%
SpS37.05
BVpS43.39
TBVpS19.54
PEG (NY)1.35
PEG (5Y)1.49
Graham Number100.18
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.47% | ||
| ROE | 23.51% | ||
| ROCE | 25.38% | ||
| ROIC | 20.84% | ||
| ROICexc | 25.9% | ||
| ROICexgc | 63.96% | ||
| OM | 34.11% | ||
| PM (TTM) | 27.53% | ||
| GM | 60.85% | ||
| FCFM | 32.91% |
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
ROICexc(3y)19.85%
ROICexc(5y)20.16%
ROICexgc(3y)47.68%
ROICexgc(5y)50.03%
ROCE(3y)22%
ROCE(5y)22.55%
ROICexgc growth 3Y8.61%
ROICexgc growth 5Y0.25%
ROICexc growth 3Y5.42%
ROICexc growth 5Y4.3%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.37 | ||
| Debt/EBITDA | 0.2 | ||
| Cap/Depr | 67.31% | ||
| Cap/Sales | 2.55% | ||
| Interest Coverage | 53.22 | ||
| Cash Conversion | 93.57% | ||
| Profit Quality | 119.57% | ||
| Current Ratio | 3.06 | ||
| Quick Ratio | 2.32 | ||
| Altman-Z | 11.94 |
F-Score6
WACC10.55%
ROIC/WACC1.98
Cap/Depr(3y)65.59%
Cap/Depr(5y)70.36%
Cap/Sales(3y)2.53%
Cap/Sales(5y)3.12%
Profit Quality(3y)102.06%
Profit Quality(5y)92.37%
High Growth Momentum
Growth
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.77%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%
Revenue Next Year9.97%
Revenue Next 2Y8.67%
Revenue Next 3Y7.92%
Revenue Next 5Y8.4%
EBIT growth 1Y18%
EBIT growth 3Y19.01%
EBIT growth 5Y15.82%
EBIT Next Year26.45%
EBIT Next 3Y13.99%
EBIT Next 5Y11.01%
FCF growth 1Y88.25%
FCF growth 3Y103.78%
FCF growth 5Y18.84%
OCF growth 1Y77.41%
OCF growth 3Y70.86%
OCF growth 5Y16.9%
RESMED INC / RMD Fundamental Analysis FAQ
What is the ChartMill fundamental rating of RESMED INC (RMD) stock?
ChartMill assigns a fundamental rating of 7 / 10 to RMD.
Can you provide the valuation status for RESMED INC?
ChartMill assigns a valuation rating of 5 / 10 to RESMED INC (RMD). This can be considered as Fairly Valued.
What is the profitability of RMD stock?
RESMED INC (RMD) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for RMD stock?
The Price/Earnings (PE) ratio for RESMED INC (RMD) is 22.2 and the Price/Book (PB) ratio is 5.26.
What is the financial health of RESMED INC (RMD) stock?
The financial health rating of RESMED INC (RMD) is 8 / 10.